Skip to main content

Current Drug Targets aims to cover the latest and most outstanding developments on the medicinal chemistry and pharmacology of molecular drug targets e.g. disease specific proteins, receptors, enzymes, genes. Each issue of the journal will be devoted to a single timely topic, with series of in-depth reviews, written by leaders in the field, covering a range of current topics on drug targets. These issues will be organized and led by a guest editor who is a recognized expert in the overall topic. As the discovery, identification, characterisation and validation of novel human drug targets for drug discovery continues to grow; this journal will be essential reading for all pharmaceutical scientists involved in drug discovery and development.

Publisher: Bentham Science Publishers

Volume 5, Number 1, January 2004

Book review

Review article

Dendritic Cells in Tumor Immunology and Immunotherapy
pp. 17-39(23)
Authors: Turtle, C. J.; J. Hart, D. N.

Favourites:
ADD

Neutralising Antibody, CTL and Dendritic Cell Responses to Hepatitis C Virus: A Preventative Vaccine Strategy
pp. 41-56(16)
Authors: Torresi, Joseph; Bharadwaj, Mandvi; Jackson, David C.; Gowans, Eric J.

Favourites:
ADD

Vaccine Development for Group A Streptococcus Infections and Associated Diseases
pp. 57-69(13)
Authors: Batzloff, M. R.; Sriprakash, K. S.; Good, M. F.

Favourites:
ADD

Vaccines and Vaccine Strategies Against HIV
pp. 71-88(18)
Authors: Stratov, Ivan; DeRose, Robert; Purcell, Damian F.J.; Kent, Stephen J.; au>, <

Favourites:
ADD

Alternatives to Conventional Vaccines - Mediators of Innate Immunity
pp. 89-105(17)
Authors: Eisen, D. P.; Liley, H. G.; Minchinton, R. M.

Favourites:
ADD

Addendum

Author Index to Volume 4
pp. 107-109(3)
Author: hBentham Science Publishers

Favourites:
ADD

Subject Index to Volume 4
pp. 111-117(7)
Author: Bentham Science Publishers

Favourites:
ADD

  • Access Key
  • Free ContentFree content
  • Partial Free ContentPartial Free content
  • New ContentNew content
  • Open Access ContentOpen access content
  • Partial Open Access ContentPartial Open access content
  • Subscribed ContentSubscribed content
  • Partial Subscribed ContentPartial Subscribed content
  • Free Trial ContentFree trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more